The European & Developing Countries Clinical Trials Partnership (EDCTP) aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related and neglected infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials.

Newsletter Nov 2016

Latest Newsletter with interview with EDCTP High-Representatives dr Leonardo Simão and Prof. Marcel Tanner

Read more

Strategy 2014-2024

We published an updated concise version of the Strategic Business Plan 2014-2024 with priorities per disease area.














Read more

EDCTP Awards 2016

Winners of the four EDCTP Awards 2016 received the prize at the Eighth EDCTP Forum in Lusaka, Zambia from 6-9 November 2016.

Read more

Latest news

1 December 2016

World AIDS day 2016: EDCTP’s strategy for funding research on HIV

According to the AIDS by numbers 2016 report from UNAIDS, huge progress has been made in the fight against HIV…

Read more
23 November 2016

Stakeholder meeting reports published: diarrhoeal diseases and lower respiratory tract infections

EDCTP published two reports of the stakeholder meetings on diarrhoeal diseases and lower respiratory tract infections, respectively. The meetings for…

Read more